MYCOPLANECIN DERIVATIVE

NEW MATERIAL:A compound expressed by formula I having the following characteristics: Appearance, white and amorphous powder; elemental analysis (%), C 61.54, H 8.93, N 12.51; composition formula, C51H87N9O10: mol.wt., 985; melting point, 140-150 deg.C; specific rotation, -57.7 deg. (C=0.78, chlorofo...

Full description

Saved in:
Bibliographic Details
Main Authors NAKAJIMA MUTSUO, TORIGATA AKIO, HAISHI TATSUO, ARAI MAMORU, ENOKIDA RYUZO
Format Patent
LanguageEnglish
Published 21.04.1989
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
ENZYMOLOGY
FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROCESSES USING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:NEW MATERIAL:A compound expressed by formula I having the following characteristics: Appearance, white and amorphous powder; elemental analysis (%), C 61.54, H 8.93, N 12.51; composition formula, C51H87N9O10: mol.wt., 985; melting point, 140-150 deg.C; specific rotation, -57.7 deg. (C=0.78, chloroform); solubility, soluble in methanol, acetone, ethyl acetate and chloroform and insoluble in water, benzene and n-hexane, etc. USE:An antigermicide against human tuberculosis and intermediate for producing other mycoplanecin derivative. PREPARATION:A compound expressed by formula II obtained by treating mycoplanecin with an acid or reducing mycoplanecin is treated with an acid.
Bibliography:Application Number: JP19880056902